News Headline Summary

Negative for Sarepta Pharmaceuticals (SRPT) as competitor gets orphan for Duchenne muscular dystrophy

Reaction details (15:14)

- Sarepta shares moved lower in reaction to the news before bouncing; trades USD 25.26 last.

24 Jan 2013 - 16:04 - - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: